USER FEE MCMILLAN AMENDMENT FOR FUNDING BASED ON REVIEW MILESTONES
This article was originally published in The Gray Sheet
Executive SummaryUSER FEE MCMILLAN AMENDMENT FOR FUNDING BASED ON REVIEW MILESTONES has the support of House Energy and Commerce Chairman John Dingell (D-Mich.) and Health and Environment Subcommittee Chairman Henry Waxman (D-Calif.), minority subcommittee staffers say. The amendment, written by Rep. Alex McMillan (R-N.C.), calls for staggered application fee collections by FDA as the agency progresses through the review process. The amendment is expected to be offered during full committee mark-up of the bill (HR 4864), slated to take place Aug. 9.
You may also be interested in...
The head of the European Medicines Agency is nearing the end of his tenure. We consider Guido Rasi’s achievements over the past 10 years as well as the controversies that have arisen under his leadership – and report that sailing is likely to figure in his plans for life after the agency.
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.